Dr Greg Cook, the director of access policy and advocacy for Bristol Myers Squibb Australia and New Zealand, spoke with BioPharmaDispatch about the company's submission to the parliamentary inquiry into access to new medicines and medical technologies.
-
Latest News
Time for intervention on this 'unlawful exercise of power'
An advocacy organisation has backed its call for reform of how the government funds opiate dependence by calling on a key parliamentary committee to investigate what it describes as the 'unlawful exercise of power'.
-
Latest News BMS' Dr Greg Cook on enhancing regulatory and reimbursement processes March 9, 2021
-
COVID-19 Daily updates on COVID-19 vaccine - 9 March 2021 March 9, 2021More than 304 million doses have been administered across 114 countries, according to data collected by Bloomberg. The latest rate was roughly 7.93 million doses a day. Baxter will 'fill and finish' 60-90 million doses of Moderna's mRNA vaccine. The US Centers for Disease Control and Prevention has issued new guidance to fully-vaccinated Americans.
-
Latest News PAIG companies mark International Women's Day 2021 March 9, 2021Australian-based biopharmaceutical companies have marked International Women's Day 2021 with a range of activities.
-
Australian Biotech The three women leading emerging Australian biotech March 8, 2021Emerging Adelaide-based CAR-T therapy company Carina Biotech is led by three women who have made their careers in science commercialisation.
-
Latest News Professor Paul Kelly: 'No clear signal of causality' between vaccines and deaths March 8, 2021The Department of Health has confirmed there have been deaths reported in a small number of aged care residents after they were administered a COVID-19 vaccine.
-
Latest News Next phase likely to determine whether October goal is realistic March 8, 2021The health system's 'bandwidth' to deliver over one million COVID-19 vaccine doses per week will be tested in the first few weeks of the national program's next phase that will likely indicate the extent to which the October timeline is realistic.
-
BioPharma Merck to mark International Women’s Day with new research prize March 5, 2021Merck has announced it will mark International Women’s Day (8 March) with a range of initiatives it says include the launch of a 2021 research prize aimed at helping women in APEC countries fully participate in paid work.
-
Latest News Does anyone doubt Australia would do what Italy has done? March 8, 2021How would the Australian government respond if CSL moved to export doses of the vaccine it is currently producing in Melbourne before it met its supply agreement?
-
Latest News Australia currently ranking with Ecuador, Lebanon and Gibraltar March 5, 2021More than 20 countries have administered at least one million doses of COVID-19 vaccine and there might be a little surprise at some on that list.
-
Latest News A half change that forces patients to pay the price for shortages March 5, 2021The Pharmacy Guild welcomed the change but it falls short of its own proposal because it is only allowed under strictly specified circumstances and exposes patients to high out-of-pocket costs during shortages.
-
Latest News AusBiotech searching for a new advocacy lead March 5, 2021AusBiotech is on the lookout for a new senior executive to fill the newly-created position of director of industry policy and advocacy.
-
Latest News PHARMAC denies funding and directs patient to palliative care March 4, 2021Less than a day after New Zealand Prime Minister Jacinda Ardern announced a review of PHARMAC a patient has revealed the controversial agency's dismissive attitude to her request for funded access to cancer therapy.
-
Latest News Pharmacy Guild welcomes support for reform of ODTP March 4, 2021The Pharmacy Guild has welcomed the growing support for reform of the Opiate Dependence Treatment Program and for the changes it proposed in its 2021-22 pre-Budget submission.
-
BioPharma Kazia Therapeutics signs global agreement for lead candidate March 4, 2021Emerging Australia oncology-focused biotechnology company Kazia Therapeutics (ASX:KZA) has announced a license agreement for its lead pipeline candidate Cantrixil (TRX-E-002-1).
-
BioPharma AbbVie hosts 'extravaganza' to mark the 2021 Mardi Gras Festival March 4, 2021AbbVie has held its own internal 'extravaganza' to coincide with the 2021 Mardi Gras Festival and ahead of Saturday night's parade.
-
Latest News CSL: 'We have well over one million doses in the fridge' March 3, 2021Senior representatives of CSL appeared before the ongoing Senate inquire into the federal government's response to the COVID-19 pandemic.
Australian Biotech
-
The three women leading emerging Australian biotech
March 8, 2021 -
Noxopharm launches second part of NOXCOVID-1 clinical trial
March 8, 2021 -
AusBiotech searching for a new advocacy lead
March 5, 2021 -
Research identifies cause and potential treatment for COVID-19-induced heart damage
March 4, 2021 -
Kazia Therapeutics signs global agreement for lead candidate
March 4, 2021
Other Health
-
Bupa's Emily Amos on the need for 'bold' reform
March 8, 2021 -
HBF opens its first of 15 dental centres in Perth
March 6, 2021 -
Research reveals potential risk factors for nerve damage after chemotherapy
March 4, 2021 -
New research reveals uncomfortable conversations about weight loss
March 4, 2021 -
Brisbane hospital uses AI in Asia-Pacific first
March 3, 2021
Latest Video
New Stories
-
BMS' Dr Greg Cook on enhancing regulatory and reimbursement processes
March 9, 2021 - - Latest News -
Daily updates on COVID-19 vaccine - 9 March 2021
March 9, 2021 - - COVID-19 -
PAIG companies mark International Women's Day 2021
March 9, 2021 - - Latest News -
Time for intervention on this 'unlawful exercise of power'
March 9, 2021 - - Latest News -
The three women leading emerging Australian biotech
March 8, 2021 - - Australian Biotech -
Bupa's Emily Amos on the need for 'bold' reform
March 8, 2021 - - Other Health -
Noxopharm launches second part of NOXCOVID-1 clinical trial
March 8, 2021 - - Australian Biotech